Cynata Therapeutics trial misses main targets at 24 months
Cynata Therapeutics (ASX:CYP) announced its Phase 3 trial of CYP-004 showed no statistically significant differences.
Cynata Therapeutics (ASX:CYP) announced its Phase 3 trial of CYP-004 showed no statistically significant differences.
Charger Metals NL (ASX:CHR) entered into a binding agreement to sell its total stake in the Bynoe Lithium Project to a subsidiary of Core Lithium (ASX:CXO).
Dexus Convenience Retail REIT (ASX:DXC) announced an $8.1 million portfolio valuation uplift and doubled its security buy-back target to 5%.
Commonwealth Bank (ASX:CBA) permanently appointed two internal executives to its split technology leadership team effective July 1.
IDP Education (ASX:IEL) announced an on-market share buy-back programme of up to $50 million and updated its financial expectations.
Arena REIT (ASX:ARF) stated that its portfolio valuation programme is expected to yield an $11.5 million net increase.
Holista Colltech (ASX:HCT) completed the acquisition of industrial land in Western Australia for $231,000.
Pilbara Minerals (ASX:PLS) has approved $175 million in pre-final investment decision capital expenditure.
The Australian Government announced it will provide an additional $100 million to Ukraine for critical military equipment.
SkyCity Entertainment Group (ASX:SKC) executed an agreement to resolve outstanding regulatory matters through a $21 million fine.
Rest Super has appealed a court ruling forcing the sale of its 4.5% Melbourne Airport stake managed by Dexus (ASX:DXS).
BHP (ASX:BHP) confirmed that total cost blowouts for the first two stages of its Jansen Potash Project have risen to US$4.7 billion